{"name":"Xeris Pharmaceuticals","slug":"xeris-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Glugaon RTU Injection Without Insulin Pump Reduction","genericName":"Glugaon RTU Injection Without Insulin Pump Reduction","slug":"glugaon-rtu-injection-without-insulin-pump-reduction","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Glugaon RTU Injection Without Insulin Pump Reduction","genericName":"Glugaon RTU Injection Without Insulin Pump Reduction","slug":"glugaon-rtu-injection-without-insulin-pump-reduction","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQb0NmT3hzVmJmT2Z5OGJxTm90N3hfTEdXWk5BeDI1c3ZIcWdJby1DaVRibi03WGFqaFF0SWExTDJCMVVwQXRPZDVaUF9nOVJEeW9KTWlVZGczeGo0a1plNDdON0xZbEtNT2tPblhTREQxLTAxZW5pTHR1SFl1NlhoMDFSNnpvMkRxdmtxMGtXTnV3TzNiM25HMFBhM2VXR0RYTzl4a2NqVEl5QQ?oc=5","date":"2026-02-03","type":"pipeline","source":"Seeking Alpha","summary":"Xeris Biopharma: Strong Recorlev Momentum And Pipeline Opportunity (XERS) - Seeking Alpha","headline":"Xeris Biopharma: Strong Recorlev Momentum And Pipeline Opportunity (XERS)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-10","type":"pipeline","source":"simplywall.st","summary":"Is Xeris Biopharma Holdings (XERS) Price Rally Still Justified After Recent Company Updates - simplywall.st","headline":"Is Xeris Biopharma Holdings (XERS) Price Rally Still Justified After Recent Company Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOMUgtbXhoN0paekJIMVlyV0lvY1AzS21kOUR0bm5XNTN1UFZuR3Q3YzVqT2VsQUFmQVpfMzNDUE9xZWJuY3Q1M3I0ZHVaMGhKaTFiTWpza0plM183U3ZOcTg5RzJQR2hPeUtDRnBicWtBWWJWejZtVllxaWM3MHNVclgwaWJPU2JRSkQ4T0E4eUl5a0tNMldTSG1VckpMVHRSdlI3Wl9oZWk5dnpra0hsZUdrN29aV0k?oc=5","date":"2025-01-22","type":"deal","source":"Fierce Pharma","summary":"Xeris, stymied by forgetful physicians, partners with ADA to raise awareness of need for glucagon - Fierce Pharma","headline":"Xeris, stymied by forgetful physicians, partners with ADA to raise awareness of need for glucagon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQal9yOHFic3FzZTJjZXlyNXhRM1Z4bVVLTy1rZmc3VWJTNko0cEZ6Q2hPamcybkRiSGpiU2h0OGhjSWNQQWZLVTVhY0RzdUNHR2F1NEhDMlBKSG9zRFd3VTN0U1JSUjFCUFZFaWpjcmV6cFRSRnhvMDNhQ0hJaWNyckFPQWxtMm1Tc3NpcXVSTV9CaW5IcUlfNFNBQndPMmNjWWhDaGhWZklpNWJndXNfSzhXSXR1UmtCQkNHVlRZeGhnRmZ1eDJjNVJn?oc=5","date":"2024-10-25","type":"deal","source":"Seeking Alpha","summary":"Xeris Biopharma Holdings: Promising Pipeline And Strategic Partnerships Make It Attractive - Seeking Alpha","headline":"Xeris Biopharma Holdings: Promising Pipeline And Strategic Partnerships Make It Attractive","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOVjRaeFIzcGNTcld4TTFDdnBRVkI4U0NTa3ZSSWNRU2hPYW5taFlReVg4TC1MM09EZEktYXpmSUh5S0RxQlMxSFBwNjhnRGlyZHo5UUU4eVRCcFRobmtzbTRsT016VGRYbjF3QXJrYk1fLXJhY3NYd0pJdE9QQlVqZHRpZlhJRENmd0ZXbzVyMXlUeTU0RW5mWm96NTNNY0RnZmZwd0dOZjlyaVVQZWtoN19MZXRfY1hocnFjRFVIbUY?oc=5","date":"2023-06-14","type":"regulatory","source":"Fierce Pharma","summary":"After a prolonged quiet spell, FDA ad watchers take umbrage at Xeris' 'misleading claims' for its cortisol drug Recorlev - Fierce Pharma","headline":"After a prolonged quiet spell, FDA ad watchers take umbrage at Xeris' 'misleading claims' for its cortisol drug Recorlev","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AJBVV95cUxNZk80bGFuemFoLVc2M2g0a2VvMmtCWVlyYjA2RS15b2NHeWExRThJbkhYak9LMXctTUVDNjBlS0c0TzhMWGNnZmtkUDZhVkZjN3k1ZXlfVHJqQkYxT3B0dGdnRFVaNWtXTEtfa3hxRUpvNnlaV1V2QVdmVG5QWmdRMVRXeTVLQUpVLUlxeEpwNktPeHJLOTEycFoyTTZiNm1yOHo1Y1NqU1FSMmlpU0x3UTJGbzhuRV9LMWo4aEI3TjFoVndSS3hfcXJtcVJXa1R4U1oxMkFlTXN6bVQtNDdhTGJYWEtVX1pmSDlGSENPN19ieXBHNm52dEJtVUdyRngxY3R1dnBVczZJNlhXd2tGalhaU1QxM1U3RUJpcjIzMlQySFZyaHdQdWJnQkcyVUpZODF6a1EyR2RzMHF5WEN4eDFYMll6MXpLSjB2R3RIMEhFbmhM?oc=5","date":"2022-01-13","type":"pipeline","source":"PR Newswire","summary":"PANTHERx Rare® Selected by Xeris Pharmaceuticals to Distribute Recorlev® (levoketoconazole) for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome - PR Newswire","headline":"PANTHERx Rare® Selected by Xeris Pharmaceuticals to Distribute Recorlev® (levoketoconazole) for the treatment of endogen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOai1XSG1BS0xtQzd5akVpb3IxdHItWi1mZm14NG9CMXlLWFFUYjZ2eUU0bUxzOE1TRHF3WktfeHBZZkh1QzRNZVhGbFV0Rm5yNGN4MWM4TGZJT2FOQmd3OWtnbHFNOE5fN0NzRE5XY0lKVkhtZDNZcHF6bmZBZUhVXzFFNVdmLTZZZ1lTbnU4RnQyUXAyZU9vVGVoRG15aFFRczZfa1Z5YTVPSTNyQnFkejN6MGM1Z0NGbzlv?oc=5","date":"2021-12-30","type":"regulatory","source":"Fierce Pharma","summary":"Xeris Biopharma scores FDA approval for endogenous Cushing's syndrome drug Recorlev - Fierce Pharma","headline":"Xeris Biopharma scores FDA approval for endogenous Cushing's syndrome drug Recorlev","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOSzJ6ZjllNDB3aFFIbWs1czU3V09UVEFSNXVpUGduM3FPQzcybVhUR2gydV9wVGNyZ2FuT1JoaTkxSEtXOU9qdXZOVTlDdnFEUlBJMkNyeXhBcnQ1Z1U4LXVMa2pQckpvRDBic1dLWWl1MnBJdGpYNUNURzhCZENmRXlKYk1iaWhDWFlvSlAwLVZLajd6clBWM2pWeFhNQm1W?oc=5","date":"2021-07-19","type":"pipeline","source":"MassDevice","summary":"Xeris, Tetra Pharma enter $71M licensing agreement for glucagon injection - MassDevice","headline":"Xeris, Tetra Pharma enter $71M licensing agreement for glucagon injection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNdnVNMEFjRk5YQXEzV0ZOOFpqd3hPZC1pMHJRUTBKZEtiSnRLampMSDNaVzJrR2d4Y1ZEek5LdzR4RFFkLXozMVdsbzFRemNoRVZDOHJWaUVSeDg3ZTZzZzhqc3RiT3lIVUhsMExFb0FGb1BBdFJXR09BNjU2RDFRS2Fn?oc=5","date":"2021-05-25","type":"deal","source":"Pharmaceutical Technology","summary":"Xeris Pharmaceuticals to acquire Strongbridge Biopharma for $267m - Pharmaceutical Technology","headline":"Xeris Pharmaceuticals to acquire Strongbridge Biopharma for $267m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPQjJ4LU5hTTRmU3VjYU9fZ3YtT3VxU1ZwSUU5dVNZcC1Yc3pROVVQWlBTRnhyT3VrSzItVHRxbXRubVRSTmk1LUR5cDUyZW1TTFpoSVdCVmdZZnVOV1FlbzZET3B1cFREMEFmWWlaN25vYnI0dlM0bEdfeXUtLTRka0ttYUN6TFg3WU5BTXF3?oc=5","date":"2021-05-24","type":"deal","source":"Contract Pharma","summary":"Xeris to Acquire Strongbridge Biopharma - Contract Pharma","headline":"Xeris to Acquire Strongbridge Biopharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiTkFVX3lxTE1ONEpWbUVteTNkOXJPTkFiclVGbFpyb3BqT0tBQ2xDSEdhcWU0d3k0b3NRMjc2UlFVWDVjTmU4eXVoeldaODM5ZDRrWmw4QQ?oc=5","date":"2018-06-12","type":"pipeline","source":"Yahoo Finance","summary":"Xeris Biopharma Holdings, Inc. (XERS) Stock Price, News, Quote & History - Yahoo Finance","headline":"Xeris Biopharma Holdings, Inc. (XERS) Stock Price, News, Quote & History","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNTzBDcEpJSU43a2dQMWR6RjE0Q1BpdXlnMmN6WDJDVEpwcEpjRmF4TVRBaFdIbTc5QW9KUm1yNGI0ZVBlYktNOE1SSUJ2dV9xLTlwdUVkSHoyVXQ1bVhUdTVuaTZKLUtzQlRWSGdpLWNQajRvZU1sbWJSSjBFYkJhdTk2emVtV3BJ0gGYAUFVX3lxTE94b21YRnhLbGxQRW1QekY4T3h4Y0ZwMzZucm82SHg1YUtPZTQwaWxWZmlMV3l0N1Vvc0V6ZjU0SVF5MXhNX0RiTmFfVFJuOGdWbVFWdTdPZGJ5M0xpS0h4QWVUUHpuUE9YZkpRUmNsZ0tkcjRRTjhockNUZXM1OS0wcnd4amRxU2dDdVRRcjlyUlJYR1pyMWtp?oc=5","date":"2011-12-12","type":"pipeline","source":"University of Colorado Anschutz","summary":"Xeris pharma to develop CU diabetes management drug - University of Colorado Anschutz","headline":"Xeris pharma to develop CU diabetes management drug","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}